Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Photocure ASA engages in the development and commercialization of pharmaceutical products based on photodynamic technology. Its products include Metvix for nonmelanoma skin cancer, Hexvix/Cysview for better detection and management of bladder cancer, and Cevira which is a photodynamic drug-device combination product for non-surgical treatment of high-grade cervical dysplasia. The company operates through the Commercial Franchise and Development Portfolio segments. The Commercial Franchise segment includes the sale of Hexvix/Cysview in the U.S. and Europe and other sales from partners and other products. The Development Portfolio segment focuses on the development of pipeline products. The company was founded in 1997 and is headquartered in Oslo, Norway.

Pearl Kogyo Co., Ltd. is a holding company that develops, manufactures, and markets ultrasonic equipment. Its products encompass high-frequency welder and drier, ultrasonic welders, plasma-generating powers, vacuum-forming and welding machines, trimming machines, induction heaters, and plasma application equipment. The firm serves the automobile, semiconductor manufacturers, and healthcare industries. The company was founded on October 21, 1953 and is headquartered in Osaka, Japan.

Manufactures, marketes and imports, exports pharmaceutical drugs

Research Development Foundation is an American private company that operates as noncommercial research organizations.

Manufactures pharmaceuticals

Huangshan Sanqi Biomedical Technology Co., Ltd., established on 2017-09-07, The business scope includes application research and development of Chinese herbal medicines,to plant,processing,Sales;Cultivation of primary agricultural products,research and development,processing,Sales;snake,scorpion,Bee application research and development,farming,processing,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanxi Kangbao Biological Product Co. Ltd. is a Chinese private company that manufactures pharmaceutical drugs.

Sanofi A/S engages in the production of prescription drugs as well as participates in clinical trials of present and future products. It specializes in diabetes, oncology, multiple sclerosis, rare disease and cardio vascular illnesses. The company is headquartered in Copenhagen, Denmark.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Jinan Dadongnong Biotechnology Co., Ltd., established on 2012-09-26, The business scope includes vitamin premixed feed,Micronutrient premixed feed,Compound Premixed Feed,liquid vitamin premix,Liquid trace element premixed feed,Production of liquid compound premixed feed,Sales(The validity period is subject to the license);Biotechnology development and transfer services;Research and development of animal tissue and refined antibody extraction technology;feed,Feed additives,Research and development of veterinary drug production technology;water quality,Research and development of soil improvement products;feed,Feed additives,Veterinary equipment,farming equipment,Diagnostic biological kits,Chemical Products(Free of Hazardous Chemicals)promotion of;medicine,Development of biological products,to develop,Sales;Bioengineering technology development;Daily necessities,Clothing,Leather,shoes and hats,Cleaning Products,cosmetic,skin care products,Sales of photographic equipment and online sales;Production of Medical Devices,Sales;Import and export business;food,hygiene products,Disinfectant(Free of Hazardous Chemicals),Health products,cosmetic,Pharmaceutical science and technology research and development;Sales of biochemical pesticides and microbial pesticides;Green facilities,Water treatment equipment and accessories,Design of water purification equipment,develop,to develop,Technology transfer,Technical service and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Shanghai Bode Gene Development Co., Ltd., established on 1998-03-22, Business scope includes bioengineering,Technology transfer in the field of genetic engineering expertise,technology development,technical consulting,Technical services and manufacture of related reagents and equipment,Sales;Bioengineering and Genetic Engineering Products,electronics,Chemical Products(In addition to dangerous goods)import and export business. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Shanlijian Biotechnology Co., Ltd., established on 2011-10-20, Business scope includes biotechnology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology),Engage in technology development in the field of electronic technology,technical consulting,technology transfer,Technical Services,Investment Advisory,Business Consulting,Business Management Consulting,Expo Services,Wholesale of food. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Defence Therapeutics, Inc. engages in the research and development of anti-body drug conjugates. It focuses on enhancing intracellular delivery of biological or biosimilar therapeutic drugs targeting cancer and infectious diseases. The company was founded by Simon Beaudoin on July 18, 2017 and is headquartered in Vancouver, Canada.

Hefei Fulaiduo Food Co., Ltd., established on 2011-05-10, Business scope includes licensed projects:food production;food business(Selling prepackaged food)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)